January 4th, 2022
After 2 years of validation with partners, we are very proud to announce during the 2022 JP Morgan week,
health industry’s first cloud-based “no-code” AI workbench Autosoma™
to enable scientists and clinicians to rapidly develop, validate, and deploy predictive models, and generate
healthcare insights from tens of billions of data points using robotic automation tools, all while gathering
knowledge from published clinical and cost models for the health industry. Multiple challenges drove us to
build this product during the pandemic.
Contact us to request a demo
Workforce challenges and spiraling costs
Over the past few years our team found it hard to hire personnel who could combine multiple skills: data management
and analytics with healthcare knowledge for value-based care and insights. We decided to pack in the smarts into a
“Robo-scientist” that can assist human scientists and clinicians to sift through massively large information sets
(such as EMR, claims, surveys, RPM and life-science data) by leveraging healthcare knowledge for insights and
predictive model development in multiple disease areas.
Zero tolerance on poor data quality and errors
Data errors (often due to fatigue) during intake drives wrong decisions and sub-optimal care. Our workbench employs
several clinical and business rules to ensure high quality data for AI/ML modeling and analyses. The workbench
eliminates hundreds of hours of manual steps, data errors, and related costs, while empowering healthcare stakeholders
to focus on reducing biases, selecting the right patient cohorts and building appropriate models based on factors such
as population demographics, diagnoses, social and environmental.
Learning from peer-reviewed work, and driving collaboration
Often engineers and scientists do not have enough time to review the past clinical models or just ignore past results
that have been peer-reviewed or published on specific diseases or outcomes. The workbench empowers analysts, clinicians
and scientists to leverage a vast pool of predictive model registries and catalog-search prior to developing new models
around hospitalization risk, resource utilization and cost forecasts, and allowing collaboration with clinicians on the
appropriate risk models.
Robo-scientists to automate and reduce costs
Our team developed several hundred predictive models, tested and validated them over a short period of time using the AI
workbench. A percentage of the prediction models were developed by Robo-scientists which performed nearly as well as a
human data scientist in selecting the right data and models. We envision a future where Robo-scientists will be employed
by humans to analyze complex data sets and assist decision-makers and clinicians.